Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners

Sexually Transmitted Infections

Volumn 75, Issue 4, 1999, Pages 253-257

  Piper, Margaret A ^a   Severin, Sibailly T ^b   Wiktor, Stefan Z ^b,c   Unger, Elizabeth R ^b,c   Ghys, Peter D ^b,d   Miller, Donna L ^c   Horowitz, Ira R ^e   Greenberg, Alan E ^b,c   Reeves, William C ^c   Vernon, Suzanne D ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4 count; HIV; Human papillomavirus

Indexed keywords

VIRUS DNA;

ADULT; AFRICA; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROSTITUTION; SEXUAL BEHAVIOR; VIRUS DETECTION; WART VIRUS;

EID: 0032863181     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.75.4.253     Document Type: Article

References (27)

1. 1 Feingold AR, Vermund SH, Burk RD, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J AIDS 1990;3:896-903.
2. 2 Kreiss JK, Kiviat NB, Plummer FA, et al. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Sex Transm Dis 1992;19:54-9.
3. 3 Laga M, Icenogle JP, Marsella R, et al. Genital papillomavirus infection and cervical dysplasia - opportunistic complications of HIV infection. Int J Cancer 1992;50:45-8.
4. 4 Ter Meulen J, Eberhardt HC, Luande J, et al. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992;51:515-21.
5. 5 Van Doornum GJ, Van den Hock JA, Van Ameijden EJ, et al. Cervical HPV infection among HIV-infected prostitutes addicted to hard drugs. J Med Virol 1993;41:185-90.
6. 6 Ho GY, Burk RD, Fleming I, et al. Risk of genital human papillomavirus in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994;56: 788-92.
7. 7 Seck AC, Faye MA, Critchlow CW, et al. Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV. Int J STD AIDS 1994;5:189-93.
8. 8 Sun XW, Ellerbrock TV, Lungu O, et al. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995;85:680-6.
9. 9 Langley CL, Benga-De E, Critchlow CW, et al. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high risk African women. AIDS 1996;10:413-17.
10. 10 Ferrera A, Melchers WJ, Velema JP, et al. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras. Am J Trop Med Hyg 1997;57: 138-41.
11. 11 Sun XW, Kuhn L, Ellerbrock TV, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-9.
12. 12 Johnson JC, Burnett AF, Willet GD, et al. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992;79:321-7.
13. 13 Vernon SD, Reeves WC, Clancy KA, et al. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 1994;169:1108-12.
14. 14 Vernon SD, Hart CE, Reeves WC, et al. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 1993;27:133-45.
15. 15 Buonaguro FM, Tornesello ML, Buonaguro L, et al. Role of HIV as cofactor in HPV oncogenesis: in vitro evidences of virus interactions. Antibiot Chemother 1994;46:102-9.
16. 16 De Cock KM, Adjorlolo G, Ekpini E, et al. Epidemiology and transmission of HIV-2. JAMA 1993;270:2083-6.
17. 17 Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994;265:1587-90.
18. 18 George JR, Ou CY, Parekh B, et al. Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'Ivoire. Lancet 1992;340: 337-9.
19. 19 Adjorlolo-Johnson G, De Cock KM, Epkini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994;272:462-6.
20. 20 Ghys PD, Diallo MO, Ettiègne-Traore V, et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis 1995;172:1371-4.
21. 21 De Cock KM, Porter A, Kouadio J, et al. Rapid and specific diagnosis of HIV-1 and HIV-2 infections: an evaluation of testing strategies. AIDS 1990;4:875-8.
22. 22 Svare EI, Kjaer SK, Worm AM, et al. Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence. Int J Cancer 1998;75:1-8.
23. 23 Vernon SD, Holmes KK, Reeves WC. Human papillomavirus infection and associated disease in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(Suppl 1):S121-4.
24. 24 Kjaer SK, van den Brule AJC, Bock JE, et al. Determinants of genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epid Biomarkers Prevent 1997;6:799-805.
25. 25 Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 1986;58:611-16.
26. 26 Wasserheit JN. Effect of changes in human ecology and behavior on patterns of sexually transmitted diseases, including human immunodeficiency virus infection. Proc Natl Acad Sci USA 1994;91:430-5.
27. 27 Vernon SD, Unger ER, Piper MA, et al. HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners. Sex Transm Inf 1999;75:258-60.